Given the importance of SCD1 in governing the production of phospholipids, which are the “building blocks” of tumor cells, we studied the correlation between SCD1 and SREBP1, and explored the therapeutic value of targeting SCD1 in endometrial cancer. The gene discussed is SCD; the disease is neoplasm.